Dr. Reddy's Laboratories Limited (RDY) Investment Research Dashboard
About Dr. Reddy's Laboratories Limited (RDY) stock analysis
Get live RDY stock price $11.73, comprehensive Dr. Reddy's Laboratories Limited stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time RDY stock data and investment insights.
Loading chart data...
Dr. Reddy's Laboratories Limited (RDY) Overview
Dr. Reddy's Laboratories Limited (RDY) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - Specialty & Generic industry . As of the latest trading session, RDY trades at $11.73 with a market capitalization of 9.77B . Over the past 52 weeks, RDY has traded between $11.36 and $15.67 , with the current price positioned at approximately 9% of this ra...
Key Takeaways
- Operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic)
- Market cap: 9.77B
- Current price: $11.73
- 52-week range: $11.36 - $15.67
- P/E ratio: 19.23
Investment Score
A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Dr. Reddy's Laboratories Limited, alongside its associated companies, functions as a holistic pharmaceutical entity with a global footprint. Its business operations are divided into several key divisions. The Global Generics segment is responsible fo...
Company Information
- CEO
- Erez Israeli
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 27527
Contact Information
- Website
- https://www.drreddys.com
- Address
- 8-2-337, Road No. 3
- Country
- IN
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 19.2)
✓ Lower volatility stock (Beta: 0.26) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Dr. Reddy's Laboratories Limited shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Dr. Reddy's Laboratories Limited
- ⚠Investors should consider how Dr. Reddy's Laboratories Limited fits within their overall portfolio allocation
Market Cap
9.77B
P/E Ratio (TTM)
19.23
Beta
0.26
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare RDY with peer companies:
- Price
- $62.64+3.92% (1D)
- Market cap
- 12.11B
- Price
- $116.71+2.51% (1D)
- Market cap
- 11.58B
- Price
- $25.89+1.89% (1D)
- Market cap
- 12.93B
- Price
- $182.08+2.19% (1D)
- Market cap
- 10.64B
- Price
- $55.41-0.73% (1D)
- Market cap
- 13.93B
- Price
- $179.72+1.87% (1D)
- Market cap
- 18.07B
- Price
- $182.84-2.78% (1D)
- Market cap
- 38.87B
- Price
- $111.02+2.73% (1D)
- Market cap
- 12.39B
- Price
- $85.95+6.81% (1D)
- Market cap
- 14.88B
- Price
- $17.80+1.02% (1D)
- Market cap
- 20.73B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.
Healthcare (1D)
71/100 ⭐⭐⭐⭐⭐
- Overall
- +0.9%
- NYSE
- +0.9%
- NASDAQ
- +0.9%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Financial Services | +1.5% | +2.5% | +3.6% | 19.1 | 97/100⭐⭐⭐⭐⭐ |
| Consumer Defensive | +2.3% | +4.3% | +3.2% | 30.2 | 81/100⭐⭐⭐⭐⭐ |
| Healthcare | +0.9% | +1.5% | +1.8% | 24.0 | 71/100⭐⭐⭐⭐⭐ |
| Basic Materials | +0.9% | +1.7% | +0.3% | 25.4 | 66/100⭐⭐⭐⭐ |
| Communication Services | +0.4% | -1.6% | +2.0% | 21.9 | 66/100⭐⭐⭐⭐ |
| Energy | +0.3% | -1.3% | -1.7% | 19.5 | 55/100⭐⭐⭐⭐ |
| Real Estate | -1.3% | -0.8% | -3.1% | 29.5 | 43/100⭐⭐⭐ |
| Consumer Cyclical | +0.4% | -1.6% | -5.9% | 42.4 | 23/100⭐ |
| Utilities | -3.8% | -2.8% | -7.1% | 27.0 | 22/100⭐ |
| Industrials | -1.0% | -1.2% | -11.3% | 30.4 | 18/100⭐ |
| Technology | -2.2% | -4.4% | -9.8% | 39.9 | 8/100⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-28.